Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Announces-Updates-Designed-to-Strengthen-IW-3718-Phase-III-Program-for-Refractory-Gastroesophageal-Reflux-Disease-GERD/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here